Back to Search Start Over

Minimal residual disease (MRD) monitoring by quantitative RT-PCR (RQ PCR) and FISH in chronic myelogenous leukemia (CML) patients treated with STI571 (Gleevec (R))

Authors :
Roche, C.
Grardel, N.
Valérie Soenen
Lai, Jl
Roumier, C.
Berthaud, P.
Chatelain, N.
Cosson, A.
Facon, T.
Preudhomme, C.
Source :
ResearcherID

Details

Database :
OpenAIRE
Journal :
ResearcherID
Accession number :
edsair.dedup.wf.001..09fbebe13d6407bc0cf8acebefc26e36

Tools

Authors Abstract Subjects Details